Brief Cognitive Analytic Therapy (CAT)-Informed Reformulation for Young People With Eating Disorders: A Case Series
Abstract
Background: Onset of Eating Disorder (ED) peaks in young people, and interpersonal factors can influence development and maintenance. With increased referrals to ED services, accessible, brief interventions may support early intervention and improve outcomes. Cognitive Analytic Therapy (CAT) is a transdiagnostic relational approach, which can offer benefit for a range of presenting difficulties. This study aimed to assess the feasibility and acceptability of a brief, CAT-informed reformulation for young people with ED.
Design: A case series design recruited eight young people who met inclusion and exclusion criteria to participate in the five-session reformulation intervention.
Method: Recruitment took place from NHS ED services. Feasibility and acceptability were measured via recruitment, retention, qualitative feedback and missing data. Psychological distress, ED severity, personal recovery and motivation to change were assessed at baseline, post-intervention and follow-up. Participants also completed sessional measures of psychological distress and alliance.
Results: Eight eligible participants aged 15-24 years (M = 20.25, SD = 3.58) consented to take part and received the intervention. All participants attended all intervention sessions and completed all assessments. Participants reported positive experiences of the intervention. There was an associated reduction across clinical outcomes, including psychological distress and ED severity.
Conclusions: This case series…
How strong is the evidence?
Evidence Hub reads this as a clinical trial, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.